Traded Nov 10, 2026 · largest single transaction ~$2.83MNot reported under a pre-arranged trading plan
Show all 2 transactions
Nov 10, 2026~$2.83M · 38K sh @ $75.10
DetailsOfficial recordNov 10, 2026~$303K · 4,004 sh @ $75.68
DetailsOfficial record
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
GMED · NYSE · Health Care Equipment
Globus Medical (GMED) · oqro.io/stocks/GMED · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$66.89−1.71 (−2.49%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
42 routine filings (option exercises, shares withheld for taxes, grants, gifts) are not listed here. Show them
Traded Nov 10, 2026 · largest single transaction ~$2.83MNot reported under a pre-arranged trading plan
Nov 10, 2026~$2.83M · 38K sh @ $75.10
DetailsOfficial recordNov 10, 2026~$303K · 4,004 sh @ $75.68
DetailsOfficial recordJames R. Tobin (Director) plans to sell ~$3.13M of Globus Medical
Planned, from payAnn D Rhoads (Director) sold ~$425K of Globus Medical
Planned saleAnn D. Rhoads (Director) plans to sell ~$425K of Globus Medical
Planned, from payInsider selling
Their largest sale since 2019Traded Sep 15 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade −10.4% · S&P 500 −8.9% · to Nov 20
A Globus Medical director sold $2.24M of Globus Medical shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Aug 18 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade −22.6% · S&P 500 −10.1% · to Nov 20
A Globus Medical director sold $2.18M of Globus Medical shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Jun 5 · filed 4 days laterNot reported under a pre-arranged trading plan
Since the trade −16.4% · S&P 500 −6.5% · to Nov 20
A Globus Medical director sold $2.02M of Globus Medical shares. The filing does not indicate a pre-arranged trading plan.
Kelly Huller (EVP, GC, Corporate Secretary) sold ~$1.89M of Globus Medical
Planned saleKelly Huller (EVP, GC, Corporate Secretary) sold ~$877K of Globus Medical
Planned saleKyle Kline (Senior Vice President, CFO) sold ~$363K of Globus Medical
Planned saleLeslie V Norwalk (Director) sold ~$202K of Globus Medical
Planned saleLeslie V Norwalk (Director) sold ~$355K of Globus Medical
Planned saleKelly Huller (SVP, GC, Corporate Secretary) sold ~$675K of Globus Medical
Planned saleInsider selling
Traded Nov 12, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade −21.0% · S&P 500 +0.9% · to Nov 20
A Globus Medical director sold $2.15M of Globus Medical shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Nov 11, 2025 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −21.3% · S&P 500 +1.0% · to Nov 20
A Globus Medical director sold $2.11M of Globus Medical shares. The filing does not indicate a pre-arranged trading plan.
Ann D Rhoads (Director) sold ~$648K of Globus Medical
Planned saleAnn D Rhoads (Director) sold ~$170K of Globus Medical
Planned saleAnn D Rhoads (Director) sold ~$585K of Globus Medical
Planned saleAnn D Rhoads (Director) sold ~$590K of Globus Medical
Planned saleKeith W Pfeil (COO, CFO) sold ~$1.1M of Globus Medical
Planned saleKeith W Pfeil (COO, CFO) sold ~$149K of Globus Medical
Planned saleKelly Huller (SVP, GC, Corporate Secretary) sold ~$218K of Globus Medical
Planned saleDaniel T Scavilla (President, CEO) sold ~$11.1M of Globus Medical
Planned saleTraded Nov 21 – Nov 22, 2024 · largest single transaction ~$1.13MNot reported under a pre-arranged trading plan
Nov 21, 2024~$1.13M · 13K sh @ $85.00
DetailsDavid D Davidar (Director) sold ~$1.12M of Globus Medical
Planned saleDavid D Davidar (Director) sold ~$1.13M of Globus Medical
Planned saleDavid D Davidar (Director) sold ~$575K of Globus Medical
Planned saleDavid D Davidar (Director) sold ~$573K of Globus Medical
Planned saleDaniel T Scavilla (President, CEO) sold ~$4.8M of Globus Medical
Planned saleKelly Huller (SVP, GC, Corporate Secretary) sold ~$205K of Globus Medical
Planned saleKelly Huller (SVP, GC, Corporate Secretary) sold ~$200K of Globus Medical
Planned saleDavid D Davidar (Director) sold ~$2.25M of Globus Medical
Planned saleDavid D Davidar (Director) sold ~$1.5M of Globus Medical
Planned saleKelly Huller (SVP, GC, Corporate Secretary) sold ~$563K of Globus Medical
Planned saleNov 22, 2024~$93K · 1,097 sh @ $85.02
DetailsOfficial record0 open-market purchases and 8 open-market sales by insiders of GMED between Jan 25, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 5, 2026. The data provider lists the next release for Feb 22, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 5, 2026 | 1 sale | None | 2 sales |
| Aug 6, 2026 | None | None | 1 sale |
| May 7, 2026 | None | None | 1 sale |
| Feb 24, 2026 | 1 sale | None | 1 sale |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies